human prostate stem cell line wpe stem  (ATCC)

Journal: Cell reports

Article Title: KLF4, A Gene Regulating Prostate Stem Cell Homeostasis, Is a Barrier to Malignant Progression and Predictor of Good Prognosis in Prostate Cancer

doi: 10.1016/j.celrep.2018.11.065

Figure Lengend Snippet: KEY RESOURCE TABLE

Article Snippet: The human prostate stem cell line WPE - stem was purchased from ATCC.

Techniques: Bacteria, Virus, Plasmid Preparation, Recombinant, Reverse Transcription, SYBR Green Assay, Transformation Assay, shRNA, Retroviral, Software

Journal: Oncotarget

Article Title: Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3)

doi: 10.18632/oncotarget.22152

Figure Lengend Snippet: (A) ARSB activity was measured in prostate stem cells using the exogenous substrate 4-methylumbelliferyl sulfate. ARSB activity was significantly reduced by ARSB knockdown by specific siRNA and increased by ARSB overexpression using ARSB plasmid in a pCMV6-XL4 vector in the prostate stem cells (p<0.001, n=3). GALNS silencing or overexpression did not affect the ARSB activity. (B) GALNS activity was measured using the exogenous substrate 4-methylumbelliferyl-β-D-galactoside-6-sulfateNH 4 . GALNS activity was significantly reduced by GALNS siRNA and increased by GALNS overexpression using GALNS plasmid in a pCMV6-XL4 vector (p<0.001, n=3). ARSB silencing or overexpression did not affect the GALNS activity. (C) In malignant prostate tissue, the ARSB activity was significantly lower than in the normal human prostate tissue (p<0.0001, n=6, unpaired t-test, two-tailed). (D) In contrast, the GALNS activity was significantly higher in the malignant tissue (p<0.0001, n=6, unpaired t-test, two-tailed). [ARSB = arylsulfatase B = N-acetylgalactosamine-4-sulfatase; GALNS = galactosamine-(N-acetyl)-6-sulfatase; N-acetylgalactosamine-6-sulfatase; galactose-6-sulfate sulfatase; OE = overexpression; si = siRNA].

Article Snippet: The human prostate stem cell line was obtained from ATCC (CRL-2887; Manassas, VA) and grown in Keratinocyte Serum Free Medium (K-SFM) with 0.05 mg/ml bovine pituitary extract (BPE) and 5 ng/ml epidermal growth factor (EGF), and maintained at 37°C in a humidified, 5% CO 2 environment with replenishment of media every third day, as recommended.

Techniques: Activity Assay, Knockdown, Over Expression, Plasmid Preparation, Two Tailed Test

Journal: Oncotarget

Article Title: Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3)

doi: 10.18632/oncotarget.22152

Figure Lengend Snippet: (A) Total sulfated glycosaminoglycans (GAGs) were measured using the Blyscan™ assay which detects sulfated GAGs by binding to 1,9-dimethylmethylene blue. In the prostate stem cells, total sulfated glycosaminoglycans (GAGs) were increased following silencing of ARSB or of GALNS (p<0.001, n=3). In contrast, overexpression of ARSB or of GALNS decreased the total sulfated GAGs (p<0.001, n=3). (B) Chondroitin-4-sulfate (C4S) was measured by the Blyscan™ assay, following immunoprecipitation by antibody specific for C4S. C4S was significantly increased following ARSB silencing and reduced when ARSB was overexpressed (p<0.001, n=3). Changes in GALNS expression did not affect the level of C4S. (C) Chondroitin 6-sulfate was detected by the Blyscan™ assay, following immunoprecipitation with an antibody specific for C6S. When GALNS was silenced, chondroitin 6-sulfate (C6S) increased significantly, and declined when GALNS was overexpressed (p<0.001, n=3). Changes in ARSB expression did not affect the C6S level. (D) The C4S/C6S ratio was calculated and shown to be increased when ARSB was silenced or GALNS was overexpressed (p<0.001, n=3). The ratio was reduced when ARSB was overexpressed or GALNS was silenced. (E) In the human prostate tissues, C6S and C4S were measured by the Blyscan™ assay. C4S was increased and C6S was reduced in the malignant tissue (p<0.001, n=6; unpaired t-test, two-tailed), consistent with decrease in ARSB activity and increase in GALNS activity. Overall, total sulfated GAGs were significantly increased in the malignant tissue, compared to the normal tissue (p<0.01, n=6). (F) The C4S/C6S ratio was calculated and was increased in the malignant tissue, compared to the normal tissue (p<0.001, n=6; unpaired t-test, two-tailed). [ARSB=arylsulfatase B=N-acetylgalactosamine-4-sulfatase; C4S=chondroitin 4-sulfate; C6S=chondroitin 6-sulfate; GALNS=galactosamine-(N-acetyl)-6-sulfatase; N-acetylgalactosamine-6-sulfatase; galactose-6-sulfate sulfatase; GAG=glycosaminoglycan; OE=overexpressed; si=siRNA].

Article Snippet: The human prostate stem cell line was obtained from ATCC (CRL-2887; Manassas, VA) and grown in Keratinocyte Serum Free Medium (K-SFM) with 0.05 mg/ml bovine pituitary extract (BPE) and 5 ng/ml epidermal growth factor (EGF), and maintained at 37°C in a humidified, 5% CO 2 environment with replenishment of media every third day, as recommended.

Techniques: Binding Assay, Over Expression, Immunoprecipitation, Expressing, Two Tailed Test, Activity Assay

Journal: Oncotarget

Article Title: Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3)

doi: 10.18632/oncotarget.22152

Figure Lengend Snippet: (A) Nuclear β-catenin was measured by ELISA in nuclear extracts of the prostate stem cells following ARSB and GALNS silencing and overexpression. Nuclear ß-catenin increased significantly following ARSB silencing or GALNS overexpression (p<0.001, n=3). Inversely, GALNS silencing or ARSB overexpression reduced the nuclear ß-catenin (p<0.001, n=3). (B) Nuclear ß-catenin was measured in nuclear extracts from normal and malignant human prostate tissue. Nuclear ß-catenin was significantly increased in the malignant tissue (p<0.01, unpaired t-test, two-tailed, n=6). (C) Nuclear DNA-bound TCF/LEF was determined by a transcription factor reporter assay in the prostate stem cells. A biotin-labeled TCF/LEF DNA binding sequence probe which detected TCF/LEF bound to DNA was mixed with nuclear extracts to form TCF/LEF-DNA complexes. A filter plate was used to retain the bound DNA probe and remove free probe. The bound prelabeled DNA probe was eluted from the filter and collected for quantitative determination. The bound TCF/LEF increased following either ARSB silencing or GALNS overexpression (p<0.001, n=3). In contrast, ARSB overexpression and GALNS silencing inhibited the increase (p<0.001, n=3). (D) Further demonstration of the impact of the chondroitin sulfatases was shown by effects on the mRNA expression of Wnt/ß-catenin dependent genes. QPCR showed increased expression of c-Myc and GATA-3 following ARSB silencing or GALNS overexpression. In contrast, overexpression of ARSB or silencing of GALNS reduced the mRNA expression of c-Myc and GATA-3 (p<0.001, n=6). [ARSB=arylsulfatase B=N-acetylgalactosamine-4-sulfatase; C4S=chondroitin 4-sulfate; C6S=chondroitin 6-sulfate; GALNS=galactosamine-(N-acetyl)-6-sulfatase; N-acetylgalactosamine-6-sulfatase; galactose-6-sulfate sulfatase; GAG=glycosaminoglycan; OE=overexpressed; si=siRNA; TCF/LEF=T-cell factor/lymphoid enhancer-binding factor].

Article Snippet: The human prostate stem cell line was obtained from ATCC (CRL-2887; Manassas, VA) and grown in Keratinocyte Serum Free Medium (K-SFM) with 0.05 mg/ml bovine pituitary extract (BPE) and 5 ng/ml epidermal growth factor (EGF), and maintained at 37°C in a humidified, 5% CO 2 environment with replenishment of media every third day, as recommended.

Techniques: Enzyme-linked Immunosorbent Assay, Over Expression, Two Tailed Test, Reporter Assay, Labeling, Binding Assay, Sequencing, Expressing

Journal: Oncotarget

Article Title: Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3)

doi: 10.18632/oncotarget.22152

Figure Lengend Snippet: (A) When the prostate stem cells were treated with the DNA hypomethylating agent 5-azacytidine (10 μM x 24 h), the ARSB silencing- or GALNS overexpression- induced increases in nuclear β-catenin were inhibited (p<0.001, n=3). This indicated that a transcriptional mechanism was required for the effects of ARSB siRNA and GALNS overexpression on nuclear ß-catenin. (B) Similarly, the effects of ARSB silencing or GALNS overexpression on TCF/LEF binding to nuclear DNA were inhibited by treatment with the DNA hypomethylating agent, 5-azacytidine, (p<0.001, n=3). This indicated that a transcriptional mechanism was required for the activation of Wnt/β-catenin signaling, as manifested by effects of ARSB siRNA and GALNS overexpression on TCF/LEF nuclear-DNA binding. (C) QPCR was performed using standard quantitative methods and established primers. The increased mRNA expression of c-Myc and of GATA-3 following either ARSB silencing or GALNS overexpression was inhibited by 5-azacytidine (p<0.001, n=6). These effects are consistent with dependence on DNA methylation for the observed increases in manifestations of Wnt/ß-catenin signaling following changes in activity of chondroitin sulfatases ARSB and GALNS. (D) Treatment with JW67 (4 mg/ml x 24 h), an inhibitor of the Wnt/ß-catenin signaling pathway, also blocked the ARSB silencing-induced increases in mRNA expression of c-Myc and GATA-3 (p<0.001, n=6). This finding indicates that the increased activation of Wnt/β-catenin signaling was also required to increase the expression of these Wnt target genes. (E) The effect of GALNS overexpression on mRNA expression of c-Myc and GATA-3 was also inhibited by JW67 (p<0.001, n=6). This finding indicated that the effects of ARSB silencing and GALNS overexpression on Wnt target genes were both mediated by activation of Wnt/β-catenin signaling. [ARSB=arylsulfatase B=N-acetylgalactosamine-4-sulfatase; 5-AZA=5-azacytidine; GALNS=galactosamine-(N-acetyl)-6-sulfatase; N-acetylgalactosamine-6-sulfatase; galactose-6-sulfate sulfatase; OE=overexpression; si=siRNA; TCF/LEF=T-cell factor/lymphoid enhancer-binding factor].

Article Snippet: The human prostate stem cell line was obtained from ATCC (CRL-2887; Manassas, VA) and grown in Keratinocyte Serum Free Medium (K-SFM) with 0.05 mg/ml bovine pituitary extract (BPE) and 5 ng/ml epidermal growth factor (EGF), and maintained at 37°C in a humidified, 5% CO 2 environment with replenishment of media every third day, as recommended.

Techniques: Over Expression, Binding Assay, Activation Assay, Expressing, DNA Methylation Assay, Activity Assay

Journal: Oncotarget

Article Title: Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3)

doi: 10.18632/oncotarget.22152

Figure Lengend Snippet: (A) Whole genomic DNA from prostate stem cells in which ARSB and GALNS had been silenced or overexpressed and from control samples was obtained and fractionated. Methylated DNA was isolated by binding to the methyl-CpG binding domain of human MBD2 protein, which was coupled to paramagnetic Dynabeads R M-280 Streptavidin via a biotin linker. The methylated fragments were then eluted and subjected to QPCR with specific primers to the DKK3 promoter. DKK3 promoter methylation was increased when ARSB was silenced or GALNS overexpressed (p<0.001, n=6), and reduced when GALNS was silenced or ARSB overexpressed (p<0.001, n=6). (B) By methylation specific PCR using primers specific for both the methylated and unmethylated DKK3 promoter, the expression of the methylated DKK3 promoter was demonstrated on a 2% agarose gel. Band density was increased following GALNS overexpression and ARSB silencing (p<0.001, n=3). (C) Genomic DNA was isolated from normal and malignant prostate tissue and was fractionated. The methylated dsDNA was isolated by binding to MBD2 which was coupled to Dynabeads, as above. QPCR was performed to quantify the DKK3 promoter methylation. In the malignant prostate tissue, DKK3 promoter methylation was increased (p<0.0001, n=6; unpaired t-test, two-tailed), thereby inhibiting DKK3 expression and permitting increased Wnt signaling. [ARSB=arylsulfatase B=N-acetylgalactosamine-4-sulfatase; DKK=Dickkopf inhibitor of Wnt signaling pathway; GALNS=galactosamine-(N-acetyl)-6-sulfatase; N-acetylgalactosamine-6-sulfatase; galactose-6-sulfate sulfatase; OE=overexpression; si=siRNA].

Article Snippet: The human prostate stem cell line was obtained from ATCC (CRL-2887; Manassas, VA) and grown in Keratinocyte Serum Free Medium (K-SFM) with 0.05 mg/ml bovine pituitary extract (BPE) and 5 ng/ml epidermal growth factor (EGF), and maintained at 37°C in a humidified, 5% CO 2 environment with replenishment of media every third day, as recommended.

Techniques: Control, Methylation, Isolation, Binding Assay, Expressing, Agarose Gel Electrophoresis, Over Expression, Two Tailed Test

Journal: Oncotarget

Article Title: Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3)

doi: 10.18632/oncotarget.22152

Figure Lengend Snippet: (A) Phospho-ERK1/2 was determined by sandwich ELISA, in which total ERK1/2 was first captured in the wells of an ELISA plate. A second antibody was used to detect phospho-ERK1/2. In the prostate stem cells, GALNS overexpression and ARSB silencing increased the phospho-ERK1/2 (p<0.001, n=3). In contrast GALNS silencing and ARSB OE reduced the phospho-ERK1/2 (p<0.001, n=3). The ERK activity inhibitor peptide I was effective in reversing the effect of the GALNS OE and ARSB silencing. (B) In human prostate tissue, phospho-ERK1/2 was significantly increased in the malignant tissue, compared to normal (p<0.001, n=6; unpaired t-test, two-tailed). (C) Decline in SHP2 activity, due to transfection with a dominant negative SHP2 DNA construct, led to significant increase in phospho-ERK1/2 in the prostate stem cells (p<0.001, n=3). In contrast, the constitutively active SHP2 construct reduced the phospho-ERK1/2 (p<0.001, n=3). (D) SHP2 activity was determined by measurement of phosphate released from a synthetic phosphopeptide, following isolation of SHP2 by anti-SHP2 antibody conjugated to agarose beads. ARSB silencing and GALNS overexpression reduced the SHP2 activity in the prostate stem cells (p<0.001, n=3). In contrast, GALNS silencing and ARSB overexpression increased the SHP2 activity (p<0.001, n=3). These effects are attributed to increased binding of SHP2 to C4S when ARSB was silenced or GALNS was overexpressed. (E) In the prostate stem cells, ARSB silencing significantly reduced the SHP2 activity. The dominant negative (DN) SHP2 DNA construct further reduced the SHP2 activity (p<0.001, n=3). The effect of ARSB silencing was inhibited by the constitutively active (CA) SHP2 DNA construct (p<0.001, n=3). (F) In the malignant human prostate tissue, the SHP2 activity was reduced ∼50% (p<0.001, n=6; unpaired t-test, two-tailed), attributable to the previously determined increase in C4S in the malignant tissue. (G) Both the dominant negative SHP2 DNA construct and PHPS1 (30 μM x 24 h), a chemical SHP2 inhibitor, blocked DKK3 mRNA expression. In contrast, constitutively active SHP2 increased the mRNA DKK3 expression (p<0.001, n=6). These results indicate the involvement of SHP2 in the expression of DKK3. [ARSB=arylsulfatase B=N-acetylgalactosamine-4-sulfatase; CA=constitutively active; DKK=Dickkopf Wnt inhibitory factor; DN=dominant negative; DNMT=DNA methyltransferase; ERK=extracellular-signal regulated kinase; GALNS=galactosamine-(N-acetyl)-6-sulfatase; N-acetylgalactosamine-6-sulfatase; galactose-6-sulfate sulfatase; OE=overexpression; SHP2=non-receptor tyrosine phosphatase; si=siRNA].

Article Snippet: The human prostate stem cell line was obtained from ATCC (CRL-2887; Manassas, VA) and grown in Keratinocyte Serum Free Medium (K-SFM) with 0.05 mg/ml bovine pituitary extract (BPE) and 5 ng/ml epidermal growth factor (EGF), and maintained at 37°C in a humidified, 5% CO 2 environment with replenishment of media every third day, as recommended.

Techniques: Sandwich ELISA, Enzyme-linked Immunosorbent Assay, Over Expression, Activity Assay, Two Tailed Test, Transfection, Dominant Negative Mutation, Construct, Phospho-proteomics, Isolation, Binding Assay, Expressing

Journal: The Journal of Biological Chemistry

Article Title: Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) and PH Domain and Leucine-rich Repeat Phosphatase Cross-talk (PHLPP) in Cancer Cells and in Transforming Growth Factor β-Activated Stem Cells *

doi: 10.1074/jbc.M113.537241

Figure Lengend Snippet: Epithelial-mesenchymal transition of prostate stem cells activates cross-talk between PHLPP and PTEN. A , WPE stem cells were treated with TGFβ-1 (4 ng/ml) for up to 8 days as indicated. Representative images by light microscopy (original magnification ×10) are shown. B , WPE cells were treated with TGFβ-1 for 24 h and cell proliferation was estimated by MTT assay. C , WPE cells were treated with TGFβ-1 for 8 days and lysates were analyzed for Slug, Snail, β-catenin, MMP9, and MMP2. Cdk2 was used as loading control. D , WPE cells were treated with TGFβ-1 for 8 days and the invasiveness was analyzed by invasion assay. Representative images are shown as well as a graph presenting data from three independent experiments. Results are presented as mean ± S.D. *, significantly different from controls ( p < 0.05). E and F, TGFβ-1-treated (4 ng/ml, for 8 days) WPE cells were transfected with PTEN, PHLPP1, or PHLPP2 and samples were analyzed for proteins indicated. Cdk2 was used as loading control. B , D , E, and F, results from three independent experiments are presented as mean ± S.D. *, significantly different from controls ( p < 0.05).

Article Snippet: The human prostate carcinoma cell lines DU145, 22RV1, LNCaP, PC3, prostate stem cell line WPE, immortalized prostate luminal epithelial (nontumorigenic) RWPE-1, and human breast adenocancinoma MCF7 cells were purchased from American Type Culture Collection (Manassas, VA).

Techniques: Light Microscopy, MTT Assay, Control, Invasion Assay, Transfection

Journal: The Journal of Biological Chemistry

Article Title: Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) and PH Domain and Leucine-rich Repeat Phosphatase Cross-talk (PHLPP) in Cancer Cells and in Transforming Growth Factor β-Activated Stem Cells *

doi: 10.1074/jbc.M113.537241

Figure Lengend Snippet: Phosphatase cross-talk is dependent on P2X4 receptor. A , HEK293 cells stably overexpressing empty vector were transfected with PTEN, PHLPP2, or PHLPP1 for 40 h. Cell lysates were analyzed by Western blotting, employing antibodies for PHLPP1, PHLPP2, and PTEN. B , HEK293 cells expressing P2X7 or P2X4 were transfected with PTEN, PHLPP1, or PHLPP2 for 40 h. Cell lysates were analyzed for PHLPP1, PHLPP2, and PTEN. C, Western blot analysis of the levels of P2X7, P2X4, PTEN, PHLPP1, and PHLPP2 in HEK293 stably overexpressing P2X7 or P2X4 cells. D, PC3 cells were transfected with PTEN and siRNA P2X7 or siRNA P2X4 for 40 h. Cell lysates were analyzed for P2X4, P2X7, PHLPP2, and PTEN. E , the levels of PHLPP1, PHLPP2, P2X4, P2X7, and PTEN in RWPE-1, WPE, and TGFβ-1 (4 ng/ml for 8 days) treated WPE cells were analyzed. F , TGFβ-1-treated (4 ng/ml for 8 days) WPE cells were transfected with PTEN, PHLPP1, or PHLPP2 and siRNA control or siRNA P2X4 for 40 h. Cell lysates were analyzed for P2X4, PHLPP1, PHLPP2, and PTEN. A–F , Cdk2 was used as loading control. Data from three independent experiments are presented as mean ± S.D. *, significantly different from controls ( p < 0.05).

Article Snippet: The human prostate carcinoma cell lines DU145, 22RV1, LNCaP, PC3, prostate stem cell line WPE, immortalized prostate luminal epithelial (nontumorigenic) RWPE-1, and human breast adenocancinoma MCF7 cells were purchased from American Type Culture Collection (Manassas, VA).

Techniques: Stable Transfection, Plasmid Preparation, Transfection, Western Blot, Expressing, Control

Journal: The Journal of Biological Chemistry

Article Title: Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) and PH Domain and Leucine-rich Repeat Phosphatase Cross-talk (PHLPP) in Cancer Cells and in Transforming Growth Factor β-Activated Stem Cells *

doi: 10.1074/jbc.M113.537241

Figure Lengend Snippet: P2X4 is essential for TGFβ-1-induced invasiveness and EMT. A and B , PC3 cells were treated with TGFβ-1 (0,1 ng/ml) and TNP-ATP (30 μ m ) for 48 h. A, invasiveness was analyzed and representative images (original magnification ×10) are shown as well as data from three independent experiments. Results are presented as mean ± S.D. *, significantly different from controls ( p < 0.05); #, significantly different from TGFβ-1-treated cells (*, p < 0.05). B , lysates were analyzed for MMP9. Cdk2 was used as loading control. C , PC3 cells were transfected for siRNA P2X4 for 40 h and thereafter treated with TGFβ-1 (0.1 ng/ml) for 48 h. The samples were analyzed for MMP9 and P2X4. Cdk2 was used as loading control. D , 22RV1 cells were transfected with PHLPP2 for 40 h. During transfection cells were treated with BAPTA-AM (2 μ m ). Data from three different experiments are presented. Results are presented as mean ± S.D. *, significantly different from empty vector-transfected cells (*, p < 0.05); #, significantly different from PHLPP2-transfected cells ( p < 0.05). E , WPE cells were treated with TGFβ-1 (4 ng/ml) and TNP-ATP (30 μ m ) for up to 8 days. Representative images by light microscopy (original magnification ×10) are shown. F , WPE cells were treated with TGFβ-1 (4 ng/ml) and TNP-ATP (30 μ m ) for 8 days as indicated. The lysates were analyzed for MMP9, MMP2, and β-catenin. Cdk2 was used as loading control. Data from three independent experiments are presented as mean ± S.D. *, significantly different from controls ( p < 0.05). G , WPE cells were treated with TGFβ-1 (4 ng/ml) and TNP-ATP (30 μ m ) for 8 days. Invasiveness was analyzed and representative images (original magnification ×10) are shown as well as data from three different experiments. Results are presented as mean ± S.D. *, significantly different from controls ( p < 0.05); #, significantly different from TGFβ-1-treated cells ( p < 0.05). H, levels of PTEN, PHLPP1, and PHLPP2 in liver preneoplastic tissue and control tissues from rats treated with diethyl nitrosamine (300 μmol/kg body weight) weekly for 11 weeks. Samples were analyzed for PTEN, PHLPP1, and PHLPP2. Cdk2 were used as a loading control. Densitometric analysis of data from three different rats. Results are presented as mean ± S.D. I , negative cross-talk between PTEN and PHLPP in cancer cells or activated stem cells. A scheme depicting factors implicated in the down-regulation of PHLPP in response to PTEN transfection and a similar scenario involving miR214 is envisioned for PTEN down-regulation in response to PHLPP transfection.

Article Snippet: The human prostate carcinoma cell lines DU145, 22RV1, LNCaP, PC3, prostate stem cell line WPE, immortalized prostate luminal epithelial (nontumorigenic) RWPE-1, and human breast adenocancinoma MCF7 cells were purchased from American Type Culture Collection (Manassas, VA).

Techniques: Control, Transfection, Plasmid Preparation, Light Microscopy